Norman Lloyd, Actor in St. Elsewhere and Hitchcock s Saboteur, Dies at 106
Laura Haefner, provided by
FacebookTwitterEmail
Actor, producer and director Norman Lloyd, best known for his title role in Hitchcock’s “Saboteur” and as Dr. Daniel Auschlander on NBC’s “St. Elsewhere” and famously associated with Orson Welles’ Mercury Theater, died Tuesday at his home in Los Angeles. He was 106.
His friend, producer Dean Hargrove, confirmed his death and said “His third act was really the best time of his life,” referring to the many historical Hollywood retrospectives and events Lloyd had participated in over the past few decades. Lloyd often said his secret to his long and mostly illness-free life was “avoiding disagreeable people,” Hargrove recounted.
The president of Northern Trust Asset Management discusses C-suite diversity.
Shundrawn Thomas
Shundrawn Thomas, president of $1.1 trillion Northern Trust Asset Management, has been writing letters to the industry calling for more accountability in diversity and leadership.
In Part 1 of this series, taken from an edited interview with Thomas, he explained his reasons for writing them and called for more empathy. In Part 2, we discussed how minorities have a mantle of responsibility on their shoulders when they come into positions of power and how women and minorities can create positive mentoring relationships. In Part 3, Thomas outlined an action plan for effective discussions and relationships to advance diversity within firms. In Part 4, Thomas discusses how to advance diversity, equity, and inclusion (DE&I) for both investors and leaders and the broader community.
Companies Reporting After The Bell
• VIZIO Holding (NYSE:VZIO) is estimated to report quarterly loss at $0.10 per share on revenue of $484.07 million.
• Talis Biomedical (NASDAQ:TLIS) is likely to report quarterly loss at $10.80 per share on revenue of $230.00 thousand.
• FAT Brands (NASDAQ:FAT) is estimated to report quarterly loss at $0.06 per share on revenue of $6.75 million.
• Xenon Pharmaceuticals (NASDAQ:XENE) is likely to report quarterly loss at $0.40 per share on revenue of $5.15 million.
• Sonim Technologies (NASDAQ:SONM) is expected to report quarterly loss at $0.10 per share on revenue of $12.97 million.
• Invesco National AMT-Free Municipal Bond ETFo (NYSE:PZA) is likely to report earnings for its first quarter.
Macyâs Outlines Ambitious Plan for Herald Square
Last Updated
This briefing has ended. Follow our latest coverage of
Hereâs what you need to know:
Macyâs wants to build an office tower atop its Herald Square location.Credit.FXCollaborative
Macyâs is proposing the construction of a commercial office tower on top of its flagship Herald Square store in New York as part of a broader redevelopment plan that would aim to improve the surrounding area and its subway stations.
The retailer said in a statement on Monday that it would commit $235 million to help improve the Herald Square subway stations and to âtransform Herald Square and Broadway Plaza into a modern, car-free pedestrian-friendly urban space for New Yorkers and visitors,â according to a website it created for the proposed project.
by Tyler Durden
Monday, May 10, 2021 - 08:01 AM
S&P futures started the weak flat with Nasdaq futures falling offset by surging commodity stocks as a new record in copper and iron ore prices stoked concern about whether inflation will derail a growth rebound in the world’s largest economy and spoil a record stock rally. Metal producers were among the biggest gainers in premarket trading, with Freeport-McMoRan, Cleveland-Cliffs and United States Steel all up at least 3%.
At 715 am ET, Dow e-minis were up 109 points, or 0.31%, S&P 500 e-minis were up 3.25 points, or 0.08%, and Nasdaq 100 e-minis were down 35.5 points, or 0.26%. The tech-heavy index has been whipsawed by the prospect of inflation which threatens longer-term profit expectations typical of the industry A downgrade by Citi of Internet stocks such as GOOGL did not help. Treasury yields steadied as traders brace for a busy week of auctions.